location: Current position: Home >> Scientific Research >> Paper Publications

Anti-CD19 mAb modified mesoporous titanium dioxide as exclusively targeting vector for efficient B-lymphoblastic leukemia therapy

Hits:

Date of Publication:2022-10-05

Journal:JOURNAL OF PHARMACEUTICAL SCIENCES

Affiliation of Author(s):党委组织部(党校)

Volume:110

Issue:7

Page Number:2733-2742

ISSN No.:0022-3549

Key Words:"B-lymphoblastic leukemia; CD19; DOX; Mesoporous titanium dioxide nanoparticles  (MTNs)"

Pre One:Exosomes derived from tendon stem cells promote cell proliferation and migration through the TGF beta signal pathway

Next One:Versatile biomimetic cantharidin-tellurium nanoparticles enhance photothermal therapy by inhibiting the heat shock response for combined tumor therapy